• Archives of Pharmacal Research
• /
• 제29권4호
• /
• pp.328-332
• /
• 2006

The bioequivalence and pharmacokinetics of alendronate sodium tablets were examined by determining the plasma concentration of alendronate. Two groups, consisting of 24 healthy volunteers, each received a 70 mg reference alendronate sodium tablet and a test tablet in a $2{\times}2$ crossover study. There was a 6-day washout period between doses. The plasma alendronate concentration was monitored for 7 h after the dose, using HPLC-Fluorescence Detector (FD). The area under the plasma concentration-time curve from time 0 to the last sampling time at 7 h $(AUC_{0-7h})$ was calculated using the linear-log trapezoidal rule. The maximum plasma drug concentration $(C_{max})$ and the time to reach $C_{max}(T_{max})$ were derived from the plasma concentration-time data. Analysis of variance was performed using logarithmically transformed $AUC_{0-7h}\;and\;C_{max}$, and untransformed $T_{max}$. For the test medication versus the reference medication, the $AUC_{0-7h}\;were\;87.63{\pm}29.27\;vs.\;102.44{\pm}69.96ng\;h\;mL^{-1}$ and the $C_{max}$ values were $34.29{\pm}13.77\;vs.\;38.47{\pm}24.39ng\;mL^{-1}$ respectively. The $90\%$ confidence intervals of the mean differences of the logarithmic transformed $AUC_{0-7h}$ and $C_{max}$ values were log 0.8234-log 1.1597 and log 0.8222-log 1.1409, respectively, satisfying the bioequivalence criteria guidelines of both the US Food and Drug Administration and the Korea Food and Drug Administration. The other pharmacokinetic parameters for the test drug versus reference drug, respectively, were: $t_{1/2},\;1.87{\pm}0.62\;vs.\;1.77{\pm}0.54\;h;\;V/F,\;2061.30{\pm}986.49\;vs.\;2576.45{\pm}1826.05\;L;\;CL/F,\;835.32{\pm}357.35\;vs.\;889.48{\pm}485.87\;L\;h^{-1}; K_{el},\;0.42{\pm}0.14\;vs.\;0.40{\pm}0.18\;h^{-1};\;Ka,\;4.46{\pm}3.63\;vs.\;3.80{\pm}3.64\;h^{-1};\;and\;T_{lag},\;0.19{\pm}0.09\;vs.\;0.18{\pm}0.06\;h$. These results indicated that two alendronate formulations(70-mg alendronate sodium) were biologically equivalent and can be prescribed interchangeably.

• Journal of Pharmaceutical Investigation
• /
• 제31권4호
• /
• pp.289-295
• /
• 2001

Carvedilol is an antihypertensive and antianginal compound that combines nonselective beta-adrenoceptor blocking and vasodilation properties and is devoid of intrinsic sympathomimetic activity. The purpose of the present study was to evaluate the bioequivalence of two carvedilol tablets, $Dilatrend^{TM}$ (Chong Kun Dang Pharmaceutical Co., Ltd.) and $Carvelol^{TM}$ (Dae Won Pharmaceutical Co., Ltd.), according to the prior and revised guidelines of Korea Food and Drug Administration (KFDA). The carvedilol release from the two carvedilol tablets in vitro was tested using KP VII Apparatus II method with various different kinds of dissolution media (pH 1.2, 4.0, 6.8 buffer solution, water and blend of PSB80 into water). Eighteen normal male volunteers, $24.22{\pm}1.86$ years in age and $64.81{\pm}4.56\;kg$ in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one tablet containing 25 mg of carvedilol was orally administered, blood was taken at predetermined time intervals and the concentrations of carvedilol in serum were determined using HPLC method with fluorescence detector. The dissolution profiles of two carvedilol tablets were very similar at all dissolution media. Besides, the pharmacokinetic parameters such as $AUC_t$, $C_{max}$ and $T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using non-transformed and logarithmically transformed $AUC_t$ and $C_{max}$. The results showed that the differences in $AUC_t$, $C_{max}$ and $T_{max}$ between two tablets based on the $Dilatrend^{TM}$ were 2.23%, -2.00% and 0.00%, respectively. Minimum detectable differences $({\Delta})$ at ${\alpha}=0.05$ and $1-{\beta}=0.8$ were less than 20% (e.g., 13.55% and 17.61% for $AUC_t$ and $C_{max}$, respectively). The powers $(l-{\beta})$ at ${\alpha}=0.05$, ${\Delta}=0.2$ for $AUC_t$ and $C_{max}$ were 98.08% and 88.81%, respectively. The 90% confidence intervals were within ${\pm}20%$ (e.g., $-5.69{\sim}10.16$ and $-12.30{\sim}8.30$ for $AUC_t$ and $C_{max}$, respectively). There were no sequence effect between two tablets in logarithmically transformed $AUC_t$ and $C_{max}$. The 90% confidence intervals using logarithmically transformed were within the acceptance range of log(0.8) to log(1.25) (e.g., $0.95{\sim}1.11$ and $0.89{\sim}1.09$ for $AUC_t$ and $C_{max}$, respectively). Two parameters met the criteria of prior and revised KFDA guideline for bioequivalence, indicating that $Carvelol^{TM}$ tablet is bioequivalent to $Dilatrend^{TM}$ tablet.

• Applied Biological Chemistry
• /
• 제41권5호
• /
• pp.399-404
• /
• 1998

우리 나라에서 오랫동안 식용 및 황색 색소원으로 이용되어 온 치자(Gardenia jasminoides)열매로부터 iridoid glycoside인 geniposide를 분리, 정제한 후 ${\beta}-glucosidase$로 가수분해하여 얻은 genipin을 glycine, alanine, histidine, lysine, phenylalanine, glutamate 등 여섯 종류의 아미노산과 반응시켜 수용성 치자청색소로 전환되는 과정을 규명하였다. Genipin이 아미노산과 반응하여 청색소가 되는 과정에서 pH의 영향을 알아보기 위하여 여러 pH에서 반응을 시켜본 결과 청색소 생성의 최적조건은 pH 7.0 이었고, pH 3.0 조건에서는 청색소가 전혀 생성되지 않았으며, pH 12.0 조건에서는 미량의 청색소만 생성되었다. 아미노산의 종류에 따라서도 청색소 생성량 및 색감에 차이가 있었는데 $Iysine({\lambda}_{max}=573\;nm),\;glycine({\lambda}_{max}=595 \;nm),\;phenylalanine({\lambda}_{max}=602\;nm),\;alanine({\lambda}_{max}=595\;nm)$에 비해 $histidine({\lambda}_{max}=601\;nm)$과 $glutamate({\lambda}_{max}=601\;nm)$의 경우에는 비교적 적은 양의 청색소가 생성되었다. 청색소 생성 속도상수를 여러 온도$(60,\;70,\;80,\;90^{\circ}C,\;pH\;7.0\;phosphate$ 완충용액)에서 구하였는데, 염기성 아미노산이 중성 및 산성 아미노산에 비해 생성속도가 빨랐다. 이들 값으로부터 Arrhenius 활성화에너지를 계산한 결과 $glycine(E_A=9.8\;kcal/mol)$이 다른 아미노산$(E_A=13.3{\sim}15.4\;kcal/mol)$에 비해 특히 작은 값의 활성화에너지를 나타내었다.

• Journal of Pharmaceutical Investigation
• /
• 제39권5호
• /
• pp.327-331
• /
• 2009

5-HT$_{2C}$ receptors have been considered as therapeutic targets for the treatment of various central nervous system disorders such as depression, anxiety, epilepsy, schizophrenia and sleep disorders. We chemically synthesized KKHQ80109 (K09) and KKHQ80114 (K14), selective 5-HT$_{2C}$ agonists, with the purpose of developing therapeutic agents for the treatment of obesity. The objective of this work is to investigate pharmacokinetic parameters and bioavailability of K09 and K14 in rats given orally or intravenously. Oral administration of 20 mg/kg K09 results in 4.11 hr of the terminal half-life and 89.16 ng/mL of C$_{max}$ at 5.00 hr (T$_{max}$). The terminal half-life of K14 was 3.83 hr with 215.81 ng/mL of C$_{max}$ at 3.33 hr (T$_{max}$) after oral dosing of 20 mg/kg K14, indicating that K14 is more rapidly absorbed than K09. Bioavailability showed 0.17-0.21 for K09 and 0.19-0.23 for K14. Urinary excretion of parent K09 and K14 was less than 1%, indicating that K09 and K14 undergo very extensive hepatic metabolism.

• 한국세라믹학회지
• /
• 제54권4호
• /
• pp.340-348
• /
• 2017

$SiC_f/SiC$ composites were joined using a $60{\mu}m-thick$ $Ti_3AlC_2$ or $Ti_3SiC_2$ MAX phase tape. The filler tape was inserted between the $SiC_f/SiC$ composites containing a 12 wt.% $Al_2O_3-Y_2O_3$ sintering additive. The joining was performed to a butt-joint configuration at $1600^{\circ}C$ or $1750^{\circ}C$ in an Ar atmosphere by applying 3.5 MPa using a hot press. Microstructural and phase analyses at the joining interface confirmed the decomposition of $Ti_3AlC_2$ and $Ti_3SiC_2$, indicating the joining by solid-state diffusion. The results showed sound joining interface without the presence of cracks. Joining strengths higher than 150 MPa could be obtained for the joints using $Ti_3AlC_2$ or $Ti_3SiC_2$ at $1750^{\circ}C$, while those for joined at $1600^{\circ}C$ decreased to 100 MPa approximately without the deformation of the joining bodies. The thickness of initial filler tape was reduced significantly after joining because of the decomposition and migration of MAX phase owing to the plasticity at high temperatures.

• 환경생물
• /
• 제40권2호
• /
• pp.214-223
• /
• 2022

멸강나방(Mythimna seperata)과 혹명나방(Cnaphalocrocis medinalis)은 중국 남부 양쯔강 유역에서 봄철 편서풍을 타고 국내로 유입되는 비래 해충(Migratory insect pests)으로 벼를 기주로 삼아 벼 잎을 가해하여 생육을 저해시킨다. 두 나방의 분포를 파악하기 위해서는 서식처의 온습도 뿐만 아니라 주변 환경 요소를 파악하는 것이 중요하다. 본 연구는 두 나방의 분포를 파악하기 위해서 SDM(Species Distribution Model) 중 Machine learning model인 MaxEnt (Maximum Entropy)에 출현 자료, SSPs (Shared Socio-economic Pathways) 시나리오, RCP (Representative Concentration Pathway) 시나리오를 적용하여 현재와 미래의 서식지 적합성 모형을 예측했다. 결과로 시기에 따른 서식처 면적이 큰 차이가 없었으며, SSPs 시나리오가 나빠짐에 따라 분포 면적이 넓어졌다. 두 나방은 중국으로부터 비래 후 생존하기 위한 최적의 장소가 기주가 있는 서해안과 남해안에 집중되어 있다. MaxEnt 결과 토지피복 자료, DEM (Degital Elevation Model) 순으로 기여도가 높게 나타났다. 이는 논에서의 출현 확률 높고 고도가 높아지면서 출현 확률이 낮아졌기 때문이다. 기후 변수에서 멸강나방은 BIO_4 (Temperature seasonality), 혹명나방은 BIO_2 (Mean Diurnal Range)가 높게 나타났다. 멸강나방은 계절에 의한 기온 차가 31.9℃ 이상일 때 서식처가 줄어들고, 혹명나방은 일교차 클수록 서식처가 넓어질 것으로 나타났다. 서식지 적합성 모형에서 두 나방은 대부분의 논에서 서식이 가능할 것이라 예측되었다. 하지만, 두 나방의 출현 위치를 정확하게 예측하는 데 한계가 있으므로, 서식지 적합성 지도를 기초로 조기에 대응하는 것이 중요하다고 판단된다.

• 미생물학회지
• /
• 제29권2호
• /
• pp.143-147
• /
• 1991

The root nodules and Glycine max were classified as determinate nodule based on their morphological characteristics, and isolated endosymbiont as a Bradyrhizobium based on its growth rate and single subpolar flagellum. The isolate was similar to B. japonicum USDA110 in utilization of carbon source, growth at 38.deg.C and 2% NaCl, production of $H_{2}$S and especially in the restriction endonuclease digestion pattern of symbiotic genes, allowing them to be placed in sTI group together. The former, however, grew better than the later in broad pH range from 5.0 to 9.5. Infectivity and effectivity of the isolate were confirmed by inoculation of soybean seedlings with the isolates. Characteristics of the reisolated endosymbiont from induced root nodules were identical to those of the first isolate. From these results, it was confirmed that Bradyrhizobium strain isolated from the root nodules of Glycine max was a real symbiont, and was named B. japonicum SNU001.

• 한국자기공명학회논문지
• /
• 제13권1호
• /
• pp.15-26
• /
• 2009

The NMR detection of methyl groups is of keen interest because they provide the long-range distance information required to establish global folds of high molecular weight proteins. Using longitudinal $^1H$ relaxation optimization, we achieve a gain in sensitivity of approximately 1.6-fold in the methyl-TROSY and its NOESY experiments for the 38 kDa protein mitogen activated protein kinase p38 in its fully protonated and $^{13}C$ and $^{15}N$ labeled state.

• 한국지능시스템학회논문지
• /
• 제14권6호
• /
• pp.776-782
• /
• 2004

Generally, Max-Min CRI (Compositional Rule of Inference ) method by Zadeh and Mamdani is used in the conventional fuzzy inference. However, owing to the problems of Max-Min CRI method, the inference often results in significant error regions specifying the difference between the desired outputs and the inferred outputs. In this paper, I propose a New Max-Min CRI method which can solve some problems of the conventional Max-Min CRI method. And then this method is simulated in a D.C.series motor, which is a bench marking system in control systems, and showed that the new method performs better than the other fuzzy inference methods.

• 대한화장품학회지
• /
• 제48권4호
• /
• pp.331-342
• /
• 2022

비만은 에너지의 섭취와 소비의 불균형으로 인해 지방조직이 과도하게 분화하여 과잉 축적이 되면서 발생하게 되는 대사질환 중 하나이다. 본 연구에서 저자들은 3T3-L1 지방세포를 이용해 천연 유래 6 종 혼합물인 SliMax의 항비만 효과를 확인하였다. 그 결과 SliMax는 지방분화 단계에서 후기 분화를 조절하는 것으로 알려진 PPARγ와 C/EBPα의 발현 억제를 통해 지방분화를 억제하는 결과를 보였다. 또한 지방세포 분화 유도 후 지방세포 분해 과정에서 SliMax는 지방분해 관련 단백질인 ATGL과 HSL 발현 증가를 통해 큰 사이즈의 단방성 지방구를 작은 사이즈의 수많은 다방성 지방구로 분해하였다. 마지막으로 갈색지방으로 유도하는 효능을 확인하기 위해 UCP-1의 발현과 미토콘드리아 양을 면역형광염색법으로 확인한 결과 SliMax가 지방세포의 UCP-1의 발현과 미토콘드리아 양을 증가시켰다. 결과를 종합해볼 때, 천연 유래 혼합물인 SliMax는 지방 분화억제와 지방분해 촉진을 통해 지방구의 형성을 억제하고, 열 생산과 에너지 소비와 관련된 갈색지방화 촉진 기능을 가져 항비만 소재로의 가능성을 가진다.